The one and only one patent owner for production & applications of IgY(ΔFc) antibodies in the world. This commercialized technology is solely owned by Good Biotech Corp.and is also patented-protected worldwide including all the major and dominant markets. The patents have been granted by many countries so far such as United States, Japan, Russia, Australia, China, Taiwan, New Zealand, Singapore, Malaysia, Hong Kong , Israel, etc...and now has also been granted in European Union.
